Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomipramine (PED-1/PED-2) for Premature Ejaculation
NCT01203202Phase 2Completed
- Sponsor
- Symyoo
- Start
- Sep 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clomipramine in premature ejaculation (PE) (3 arms), sponsored by Symyoo. Primary endpoint: Fold changes of Intravaginal ejaculation latency time (IELT) at 4 weeks. Started Sep 2010; status: completed.
02
Drugs
clomipramine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT01203202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203202.